Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants
- PMID: 31061331
- DOI: 10.1248/bpb.b19-00085
Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants
Abstract
Acyl-CoA synthetase long-chain family members (ACSLs) are a family of enzymes that convert long-chain free fatty acids into their acyl-CoAs. ACSL4 is an ACSL isozyme with a strong preference for arachidonic acid (AA) and has been hypothesized to modulate the metabolic fates of AA. There are two ACSL4 splice variants: ACSL4V1, which is the more abundant transcript, and ACSL4V2, which is believed to be restricted to the brain. In the present study, we expressed recombinant human ACSL4V1 and V2 in Spodoptera frugiperda 9 (Sf9) cells using the baculovirus expression system and then partially purified both variants by cobalt affinity column chromatography. We then established a novel ACSL assay system with LC-MS/MS, which is highly sensitive and applicable to various kinds of fatty acids, and used it to investigate the substrate specificity of recombinant human ACSL4V1 and V2. The results showed that both ACSL4 variants preferred various kinds of highly unsaturated fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic acid) and eicosapentaenoic acid (EPA), as well as AA as a substrate. Moreover, our kinetic studies revealed that the two variants had similar relative affinities for AA, EPA and DHA but different reaction rates for each HUFA. These results confirmed the importance of both of ACSL4 variants in the maintenance of membrane phospholipids bearing HUFAs. Structural analysis of these variants might reveal the molecular mechanism by which they maintain membrane phospholipids bearing HUFAs.
Keywords: ACSL4; acyl-CoA synthetase long-chain family member (ACSL); adrenic acid; arachidonic acid; highly unsaturated fatty acid.
Similar articles
-
Substrate Specificity of Human Long-Chain Acyl-CoA Synthetase ACSL6 Variants.Biol Pharm Bull. 2021;44(10):1571-1575. doi: 10.1248/bpb.b21-00551. Biol Pharm Bull. 2021. PMID: 34602568
-
Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Nov;1864(11):1606-1618. doi: 10.1016/j.bbalip.2019.07.013. Epub 2019 Jul 31. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 31376475
-
Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.Biochim Biophys Acta. 2014 Jan;1841(1):44-53. doi: 10.1016/j.bbalip.2013.09.015. Epub 2013 Oct 1. Biochim Biophys Acta. 2014. PMID: 24095834
-
Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.Prostaglandins Other Lipid Mediat. 2019 Oct;144:106363. doi: 10.1016/j.prostaglandins.2019.106363. Epub 2019 Jul 12. Prostaglandins Other Lipid Mediat. 2019. PMID: 31306767 Review.
-
Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.World J Gastroenterol. 2015 Mar 28;21(12):3492-8. doi: 10.3748/wjg.v21.i12.3492. World J Gastroenterol. 2015. PMID: 25834313 Free PMC article. Review.
Cited by
-
Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials.Front Pharmacol. 2022 Apr 19;13:858676. doi: 10.3389/fphar.2022.858676. eCollection 2022. Front Pharmacol. 2022. PMID: 35517803 Free PMC article. Review.
-
Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease.Front Nutr. 2021 Nov 17;8:744825. doi: 10.3389/fnut.2021.744825. eCollection 2021. Front Nutr. 2021. PMID: 34869521 Free PMC article.
-
The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer.Cancers (Basel). 2024 Mar 16;16(6):1170. doi: 10.3390/cancers16061170. Cancers (Basel). 2024. PMID: 38539505 Free PMC article.
-
ACSL4: biomarker, mediator and target in quadruple negative breast cancer.Oncotarget. 2023 Jun 12;14:563-575. doi: 10.18632/oncotarget.28453. Oncotarget. 2023. PMID: 37306503 Free PMC article. Review.
-
Targeting Acyl-CoA synthetase long-chain family member 4: a potential approach for the treatment of cerebral ischemia/reperfusion injury.Metab Brain Dis. 2025 May 26;40(5):212. doi: 10.1007/s11011-025-01638-2. Metab Brain Dis. 2025. PMID: 40418418 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials